Form:DrugProjectForm: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
mNo edit summary
Line 10: Line 10:
----
----


<BIG><BIG>'''''1. BEFORE YOU START'''''</BIG></BIG>
<BIG><BIG>'''''1.&nbsp;&nbsp;Read before you proceed'''''</BIG></BIG>


----
----


'''''1.1 Resources'''''
'''''1.1&nbsp;&nbsp;Resources'''''


----
----


'''''1.1.1 [http://dailymed.nlm.nih.gov/dailymed/about.cfm DailyMed]'''''
'''''1.1.1&nbsp;&nbsp;[http://dailymed.nlm.nih.gov/dailymed/about.cfm DailyMed]'''''


: 1.1.1.1 DailyMed is a public service provided by the National Library of Medicine (NLM) that encompasses FDA approved labels (package inserts) of marketed drugs.
: 1.1.1.1&nbsp;&nbsp;DailyMed is a public service provided by the National Library of Medicine (NLM) that encompasses FDA approved labels (package inserts) of marketed drugs.


'''''1.1.2 [http://www.accessdata.fda.gov/Scripts/cder/drugsatfda/index.cfm Drugs@FDA]'''''
'''''1.1.2&nbsp;&nbsp;[http://www.accessdata.fda.gov/Scripts/cder/drugsatfda/index.cfm Drugs@FDA]'''''


: 1.1.2.1 Drugs@FDA is a searchable catalog of FDA approved drug products (both prescription and over the counter) which is also useful for confirmation of the marketing status.
: 1.1.2.1&nbsp;&nbsp;Drugs@FDA is a searchable catalog of FDA approved drug products (both prescription and over the counter) which is also useful for confirmation of the marketing status.


'''''1.1.3 [http://pillbox.nlm.nih.gov/pillimage/search.php Pillbox]'''''
'''''1.1.3&nbsp;&nbsp;[http://pillbox.nlm.nih.gov/pillimage/search.php Pillbox]'''''


: 1.1.3.1 Pillbox is developed to aid in the identification of unknown pills (oral solid dosage form medications). It combines images of pills with appearance and other information to enable users to visually search for and identify oral solid dosage form medications.  
: 1.1.3.1&nbsp;&nbsp;Pillbox is developed to aid in the identification of unknown pills (oral solid dosage form medications). It combines images of pills with appearance and other information to enable users to visually search for and identify oral solid dosage form medications.  


: 1.1.3.2 Once a pill has been identified, additional information is provided, including brand/generic name, ingredients, and the National Drug File identification number.
: 1.1.3.2&nbsp;&nbsp;Once a pill has been identified, additional information is provided, including brand/generic name, ingredients, and the National Drug File identification number.


: 1.1.3.3 Links are provided to NLM drug information resources, such as drug labels from DailyMed and the Drug Information Portal, which searches NIH and FDA drug information resources.  
: 1.1.3.3&nbsp;&nbsp;Links are provided to NLM drug information resources, such as drug labels from DailyMed and the Drug Information Portal, which searches NIH and FDA drug information resources.  


'''''1.1.4 [http://druginfo.nlm.nih.gov/drugportal/ Drug Information Portal]'''''
'''''1.1.4&nbsp;&nbsp;[http://druginfo.nlm.nih.gov/drugportal/ Drug Information Portal]'''''


: 1.1.4.1 Drug Information Portal provides links to information on breastfeeding (LactMed), drug-induced liver injury (LiverTox), manufacturers drug label (DailyMed), clinical trials (ClinicalTrials.gov), and drug Identification and Image Display (Pillbox beta).
: 1.1.4.1&nbsp;&nbsp;Drug Information Portal provides links to information on breastfeeding (LactMed), drug-induced liver injury (LiverTox), manufacturers drug label (DailyMed), clinical trials (ClinicalTrials.gov), and drug Identification and Image Display (Pillbox beta).


: 1.1.4.2 For detailed information, it also provides links to reviewed biological and physical data (HSDB), references from scientific journals (Medline/PubMed), references from toxicological journals (TOXLINE), biological activities and chemical structures (PubChem), biological activities against HIV/AIDS and other viruses (NIAID ChemDB), toxicological and chemical resources (ChemIDplus), information from the US Food & Drug Administration (Drugs@FDA), and information from the US Drug Enforcement Administration (DEA)
: 1.1.4.2&nbsp;&nbsp;For detailed information, it also provides links to reviewed biological and physical data (HSDB), references from scientific journals (Medline/PubMed), references from toxicological journals (TOXLINE), biological activities and chemical structures (PubChem), biological activities against HIV/AIDS and other viruses (NIAID ChemDB), toxicological and chemical resources (ChemIDplus), information from the US Food & Drug Administration (Drugs@FDA), and information from the US Drug Enforcement Administration (DEA)


'''''1.1.5 [http://www.nlm.nih.gov/medlineplus/druginformation.html MedlinePlus]'''''
'''''1.1.5 [http://www.nlm.nih.gov/medlineplus/druginformation.html MedlinePlus]'''''


: 1.1.5.1 MedlinePlus is a service of the National Library of Medicine (NLM) which contains information for drugs, herbs, and supplements.
: 1.1.5.1&nbsp;&nbsp;MedlinePlus is a service of the National Library of Medicine (NLM) which contains information for drugs, herbs, and supplements.


----
----


'''''1.2 Generic name, active ingredient, formulation, combination, trade name, label'''''
'''''1.2&nbsp;&nbsp;Generic name, active ingredient, compound, combination, trade name, formulation, and label'''''


----
----


'''''1.2.1 What is the generic name?'''''
'''''1.2.1&nbsp;&nbsp;What is the generic name?'''''


: 1.2.1.1 Search and confirm the generic name of the drug.
: 1.2.1.1&nbsp;&nbsp;Search and confirm the generic name of the drug.


: 1.2.1.2 Use the generic name as the title of the landing page.
: 1.2.1.2&nbsp;&nbsp;Use the generic name as the title of the landing page.


'''''1.2.2 What is the active ingredient? Is there more than one formulation for the active ingredient?'''''
'''''1.2.2&nbsp;&nbsp;What is the active ingredient? Is there more than one compound for the active ingredient?'''''


: 1.2.2.1 Search and confirm the formulation(s) of the active ingredient.
: 1.2.2.1&nbsp;&nbsp;Search and confirm the compound(s) of the active ingredient.


: 1.2.2.2 If there is more than one formulation, place links (as &lt;h3&gt; headings) of each formulation on the top of the landing page.
: 1.2.2.2&nbsp;&nbsp;If there is more than one type of compound, place links (as &lt;h3&gt; headings) of each compound at the top of the landing page.


'''''1.2.3 Is the active ingredient provided as combinations with other active ingredients?'''''
'''''1.2.3&nbsp;&nbsp;Is the active ingredient provided as combinations with other active ingredients?'''''


: 1.2.3.1 If the active ingredient is also provided as combinations with other active ingredients, place links (as &lt;h3&gt; headings) of each combination on the top of the landing page.
: 1.2.3.1&nbsp;&nbsp;If the active ingredient is also provided as combinations with other active ingredients, place links (as &lt;h3&gt; headings) of each combination at the top of the landing page.


'''''1.2.4 What is the trade name?'''''
'''''1.2.4&nbsp;&nbsp;What is the trade name?'''''


: 1.2.4.1 Search and confirm the trade names for the generic name. Please note that the trade name may be identical to the generic name in certain cases.
: 1.2.4.1&nbsp;&nbsp;Search and confirm the trade names for the generic name and its compounds. Please note that the trade name may be identical to the generic name in certain cases.


: 1.2.4.2 Search and confirm the trade names for each formulation and combination (if any). Different formulations may have identical trade names.
: 1.2.4.2&nbsp;&nbsp;Search and confirm the trade names for each combination (if any).


: 1.2.4.3 Include the trade names of each formulation and/or combination in parentheses.
: 1.2.4.3&nbsp;&nbsp;List the trade names of each compound and/or combination in parentheses.


: 1.2.4.4 Sort the list of formulations and/or combinations in alphabetical order.
: 1.2.4.4&nbsp;&nbsp;Sort the list of compunds and/or combinations in alphabetical order.


'''''1.2.5 Which label should be used?'''''
'''''1.2.5&nbsp;&nbsp;What is the formulation?'''''


: 1.2.5.1 Check the ''Marketing Start Date'' and the ''Revised date'' at the end of the label.  
: 1.2.5.1&nbsp;&nbsp;Learn the concept of pharmaceutical formulations '''[[Pharmaceutical formulation|here]]'''.


: 1.2.5.2 For a specific formulation of an active ingredient, use the label that is most recently updated as a reference.
: 1.2.5.2&nbsp;&nbsp;Search and confirm the formulations for the generic name and its compounds and combinations. Please note that different formulations may have identical trade names.


'''''1.2.6 Example'''''
'''''1.2.6&nbsp;&nbsp;Which label should be used?'''''


: For the generic name '''metoprolol''', there are two formulations of the active ingredient: '''metoprolol succinate''' and '''metoprolol tartrate'''.
: 1.2.6.1&nbsp;&nbsp;Check the ''Marketing Start Date'' and the ''Revised date'' at the end of the label.


: The formulations, combinations, and trade names are as follows:
: 1.2.6.2&nbsp;&nbsp;Choose the label that is most recently updated as a reference.
 
'''''1.2.7&nbsp;&nbsp;Example'''''
 
: For the generic name '''Metoprolol''', there are two compounds of the active ingredient: '''metoprolol succinate''' and '''metoprolol tartrate'''.
 
: Available compounds, combinations, and trade names of '''Metoprolol''' are as follows:


: '''[[Metoprolol succinate]] ([[Toprol XL]], [[Toprolxl XL]])'''
: '''[[Metoprolol succinate]] ([[Toprol XL]], [[Toprolxl XL]])'''
Line 100: Line 106:
----
----


<BIG><BIG>'''''2. Creating or editing a drug page'''''</BIG></BIG>
<BIG><BIG>'''''2.&nbsp;&nbsp;Creating or editing a drug page'''''</BIG></BIG>


----
----


'''''2.1 Landing page'''''
'''''2.1&nbsp;&nbsp;Landing page'''''


----
----


'''''2.1.1 Go to WikiDoc.'''''
'''''2.1.1&nbsp;&nbsp;Go to WikiDoc.'''''


'''''2.1.2 Search with the generic name.'''''
'''''2.1.2&nbsp;&nbsp;Search with the generic name.'''''


'''''2.1.3 The generic name page should be organized as a landing page if multiple formulations or combinations exist.'''''
'''''2.1.3&nbsp;&nbsp;The generic name page should be organized as a landing page if multiple compounds exist.'''''


'''''2.1.4 At the top of the landing page, place the links (as &lt;h3&gt; headings) of formulations and/or combinations followed by trade names in parentheses (See Section 1.2 for instructions).'''''
'''''2.1.4&nbsp;&nbsp;At the top of the landing page, place the links (as &lt;h3&gt; headings) of compounds and/or combinations followed by trade names in parentheses (See Section 1.2 for instructions).'''''


: 2.1.4.1 &lt;h3&gt; headings should begin and end with three "=" signs.
: 2.1.4.1&nbsp;&nbsp;&lt;h3&gt; headings should begin and end with three "=" signs.


: 2.1.4.2 Example: <nowiki>===[[Metoprolol succinate]] ([[Toprol XL]], [[Toprolxl XL]])===</nowiki>
: 2.1.4.2&nbsp;&nbsp;Example: <nowiki>===[[Metoprolol succinate]] ([[Toprol XL]], [[Toprolxl XL]])===</nowiki>


'''''2.1.5 Redirect the trade name pages to the generic name with formulation pages.'''''
'''''2.1.5&nbsp;&nbsp;Redirect the trade name pages to its generic compound page.'''''


: 2.1.5.1 Example 1: Redirect '''[[Lopressor]]''' to '''[[Metoprolol tartrate]]'''.
: 2.1.5.1&nbsp;&nbsp;Example 1: Redirect '''[[Lopressor]]''' to '''[[Metoprolol tartrate]]'''.


: 2.1.5.2 Example 2: Redirect both '''[[Toprol XL]]''' and '''[[Toprolxl XL]]''' to '''[[Metoprolol succinate]]'''.
: 2.1.5.2&nbsp;&nbsp;Example 2: Redirect both '''[[Toprol XL]]''' and '''[[Toprolxl XL]]''' to '''[[Metoprolol succinate]]'''.


'''''2.1.6 Create or edit the Overview section and Category section.'''''
'''''2.1.6&nbsp;&nbsp;Create or edit the Overview section and Category section.'''''


: 2.1.6.1 The Overview section should include information about the drug class, usage, and adverse reactions.
: 2.1.6.1&nbsp;&nbsp;The Overview section should include information about the drug class, usage, and adverse reactions.


: 2.1.6.2 The Category section should include all applicable categories for the drug in alphabetical order.
: 2.1.6.2&nbsp;&nbsp;The Category section should include all applicable categories for the drug in alphabetical order.


: 2.1.6.3 The name of category should be identical to the official FDA category.
: 2.1.6.3&nbsp;&nbsp;The name of category should be identical to the official FDA category.


----
----


'''''2.2 Using the Drug Project Form'''''
'''''2.2&nbsp;&nbsp;Using the Drug Project Form'''''


----
----


'''''2.2.1 To create a drug page, Go to [[Form:DrugProjectForm]].'''''
'''''2.2.1&nbsp;&nbsp;To create a drug page, Go to [[Form:DrugProjectForm]].'''''


'''''2.2.2 Use the appropriate title for the drug page.'''''
'''''2.2.2&nbsp;&nbsp;Use the appropriate title for the drug page.'''''


: 2.2.2.1 If there is more than one formulation for a generic name, use the generic name with formuation as the title.
: 2.2.2.1&nbsp;&nbsp;If there is more than one compound for a generic name, use the generic name with compound as the title.


:: 2.2.2.1.1 Example 1: Use '''Metoprolol succinate''' as the title.
:: 2.2.2.1.1&nbsp;&nbsp;Example 1: Use '''Metoprolol succinate''' as the title.


:: 2.2.2.1.2 Example 2: Use '''Metoprolol tartrate''' as the title.
:: 2.2.2.1.2&nbsp;&nbsp;Example 2: Use '''Metoprolol tartrate''' as the title.


: 2.2.2.2 If there are combinations with other active ingredients, use the combination of each ingredient separated by the word "and" as the title.
: 2.2.2.2&nbsp;&nbsp;If there are combinations with other active ingredients, use the combination of each ingredient separated by the word "and" as the title.


:: 2.2.2.2.1 Example 1: '''Metoprolol succinate and Hydrochlorothiazide''' as the title.
:: 2.2.2.2.1&nbsp;&nbsp;Example 1: '''Metoprolol succinate and Hydrochlorothiazide''' as the title.


:: 2.2.2.2.2 Example 2: '''Metoprolol tartrate and Arginine''' as the title.
:: 2.2.2.2.2&nbsp;&nbsp;Example 2: '''Metoprolol tartrate and Arginine''' as the title.


'''''2.2.3 Enter the title for the drug page in the field and left-click on the "Create or edit a Drug Page" button.'''''
'''''2.2.3&nbsp;&nbsp;Enter the title for the drug page in the field and left-click on the "Create or edit a Drug Page" button.'''''


'''''2.2.4 Follow the instructions under each tab to insert contents.'''''
'''''2.2.4&nbsp;&nbsp;Follow the instructions under each tab to insert contents.'''''


'''''2.2.5 Left-click on the "Save page" button after completing each tab to minimize the risk of losing progress.'''''
'''''2.2.5&nbsp;&nbsp;Left-click on the "Save page" button after completing each tab to minimize the risk of losing progress.'''''


'''''2.2.6 Quality check the completed section before proceeding to the next section.'''''
'''''2.2.6&nbsp;&nbsp;Quality check the completed section before proceeding to the next section.'''''


----
----
Line 169: Line 175:


{|
{|
| style="width: 50%;" valign=top | Please enter the generic drug name here: {{{field|genericName|input type=text| size=40}}}
| style="width: 50%;" valign=top | Please enter the '''generic name''' here: {{{field|genericName|input type=text| size=40}}}
|-
|-
| valign=top | Please indicate the Class to which the drug belongs {{{field|aOrAn|input type=dropdown|values=a,an}}}:<BR><SMALL>
| style="width: 50%;" valign=top | Please indicate the '''class''' to which the drug belongs {{{field|aOrAn|input type=dropdown|values=a,an}}}:<BR><SMALL>
* '''Step 1: Search with the generic name at [http://druginfo.nlm.nih.gov/drugportal/ Drug Information Portal]'''<BR>
* '''Step 1: Search with the generic name at [http://druginfo.nlm.nih.gov/drugportal/ Drug Information Portal]'''<BR>
* '''Step 2: Match the collected categories with [http://dailymed.nlm.nih.gov/dailymed/browseClasses.cfm FDA Established Pharmacologic Classes]'''</SMALL>
* '''Step 2: Match the collected categories with [http://dailymed.nlm.nih.gov/dailymed/browseClasses.cfm FDA Established Pharmacologic Classes]'''</SMALL>
| valign=top | {{{field|drugClass|input type=two listboxes|values=5-Alpha reductase inhibitor,5-Lipoxygenase inhibitor,Acetylcholine release inhibitor,Acetylcholine releasing agent,Actinomycin,Adenosine receptor agonist,Adrenal steroid synthesis inhibitor,Adrenergic receptor agonist,Adrenocorticotropic hormone,Aldehyde dehydrogenase inhibitor,Aldosterone antagonist,Alkylating drug,Allogeneic cord blood hematopoietic progenitor cell therapy,Allogeneic cultured cell scaffold,Allylamine antifungal,Alpha-adrenergic agonist,Alpha-adrenergic blocker,Alpha-glucosidase inhibitor,Aluminum complex,Amide local anesthetic,Amino acid,Amino acid hypertonic solution,Aminoglycoside antibacterial,Aminoketone,Aminosalicylate,Amphenicol-class antibacterial,Amphetamine anorectic,Amylin analog,Androgen,Androgen receptor inhibitor,Angiontensin converting enzyme inhibitor,Angiotensin 2 receptor blocker,Angiotensin converting enzyme inhibitor,Anthracycline topoisomerase inhibitor,Anti-anginal,Anti-coagulant,Anti-epileptic agent,Anti-IgE,Anti-inhibitor coagulant complex,Antiarrhythmic,Anticholinergic,Antidiarrheal,Antidote,Antidote for acetaminophen overdose,Antiemetic,Antifibrinolytic agent,Antihelminthic,Antihistamine,Antimalarial,Antimetabolite,Antimetabolite immunosuppressant,Antimycobacterial,Antiparasitic,Antiprotozoal,Antirheumatic agent,Antiseptic,Antivenin,Aromatase inhibitor,Aromatic amino acid decarboxylation inhibitor,Arteriolar vasodilator,Asparagine-specific enzyme,Atypical antipsychotic,Autologous cellular immunotherapy,Autologous cultured cell,Autonomic ganglionic blocker,Azole antifungal,B lymphocyte stimulator-specific inhibitor,Barbiturate,Benzodiazepine,Benzodiazepine antagonist,Benzothiazole,Benzylamine antifungal,Beta lactamase inhibitor,Beta-adrenergic agonist,Beta-adrenergic blocker,Beta2-adrenergic agonist,Beta3-adrenergic agonist,Biguanide,Bile acid,Bile acid sequestrant,Bismuth,Bisphosphonate,Blood coagulation factor,Blood viscosity reducer,Bovine intestinal adenosine deaminase,Bradykinin B2 receptor antagonist,Calcineurin inhibitor immunosuppressant,Calcitonin,Calcium,Calcium channel blocker,Calcium-sensing receptor agonist,Calculi dissolution agent,Cannabinoid,Carbamoyl phosphate synthetase 1 activator,Carbonic anhydrase inhibitor,Cardiac glycoside,Carnitine analog,Catechol-O-methyltransferase inhibitor,Catecholamine,Catecholamine synthesis inhibitor,Catecholamine-depleting sympatholytic,CCR5 co-receptor antagonist,CD20-directed cytolytic antibody,CD20-directed radiotherapeutic antibody,CD25-directed cytotoxin,CD3 blocker immunosuppressant,CD30-directed immunoconjugate,CD52-directed cytolytic antibody,Cell death inducer,Central alpha-2 adrenergic agonist,Central nervous system depressant,Central nervous system stimulant,Cephalosporin antibacterial,Chloride channel activator,Cholecystokinin analog,Cholinergic muscarinic agonist,Cholinergic muscarinic antagonist,Cholinergic nicotinic agonist,Cholinergic receptor agonist,Cholinesterase inhibitor,Cholinesterase reactivator,Collagen-specific enzyme,Complement inhibitor,Contrast agent for ultrasound imaging,Copper absorption inhibitor,Copper-containing intrauterine device,Corticosteroid,Cysteine depleting agent,Cystic fibrosis transmembrane conductance regulator potentiator,Cytochrome p450 2D6 inhibitor,Cytomegalovirus nucleoside analog DNA polymerase inhibitor,Cytoprotective agent,Decarboxylase inhibitor,Demulcent,Depigmenting agent,Depolarizing neuromuscular blocker,Diagnostic dye,Dietary cholesterol absorption inhibitor,Dihydrofolate reductase inhibitor antibacterial,Dihydrofolate reductase inhibitor antimalarial,Dihydropyridine calcium channel blocker,Dipeptidyl peptidase 4 inhibitor,Direct thrombin inhibitor,Dopamine-2 receptor antagonist,Dopaminergic agonist,Echinocandin antifungal,Endoglycosidase,Endothelin receptor antagonist,Epidermal growth factor receptor antagonist,Ergot derivative,Ergot-derived dopamine receptor agonist,Ergotamine derivative,Erythropoiesis-stimulating agent,Ester local anesthetic,Estrogen,Estrogen agonist/antagonist,Estrogen receptor antagonist,Factor VIII activator,Factor Xa inhibitor,Folate analog,Folate analog metabolic inhibitor,Gadolinium-based contrast agent,Gamma-aminobutyric acid a receptor agonist,Gamma-aminobutyric acid-ergic agonist,General anesthetic,Glinide,GLP-1 receptor agonist,Glucosylceramide synthase inhibitor,Glycopeptide antibacterial,Glycosaminoglycan,Gonadotropin,Gonadotropin releasing hormone antagonist,Gonadotropin releasing hormone receptor agonist,Growth hormone releasing factor analog,Guanylate cyclase-C agonist,Hedgehog pathway inhibitor,Helicobacter pylori diagnostic,Hematopoietic stem cell mobilizer,Heparin reversal agent,Hepatitis B virus nucleoside analog reverse transcriptase inhibitor,Hepatitis C virus NS3/4a protease inhibitor,Her2 receptor antagonist,Herpes simplex virus nucleoside analog dna polymerase inhibitor,Herpes zoster virus nucleoside analog dna polymerase inhibitor,Herpesvirus nucleoside analog dna polymerase inhibitor,Histamine-1 receptor antagonist,Histamine-1 receptor inhibitor,Histamine-2 receptor antagonist,Histone deacetylase inhibitor,HMG-CoA reductase inhibitor,Human alpha-1 proteinase inhibitor,Human antihemophilic factor,Human blood coagulation factor,Human C1 esterase inhibitor,Human immunodeficiency virus 1 fusion inhibitor,Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor,Human immunodeficiency virus integrase strand transfer inhibitor,Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor,Human immunoglobulin,Human immunoglobulin G,Human platelet-derived growth factor,Human serum albumin,Hydrolytic lysosomal glucocerebroside-specific enzyme,Hydrolytic lysosomal glycogen-specific enzyme,Hydrolytic lysosomal glycosaminoglycan-specific enzyme,Hydrolytic lysosomal neutral glycosphingolipid-specific enzyme,Hydroxyphenyl-pyruvate dioxygenase inhibitor,Immunoglobulin G,Inactivated Salmonella typhi vaccine,Influenza A M2 protein inhibitor,Inhalation diagnostic agent,Insulin,Insulin analog,Integrin receptor antagonist,Interferon alpha,Interferon gamma,Interleukin-1 receptor antagonist,Interleukin-2 receptor blocking antibody,Intestinal lipase inhibitor,Iron chelator,Ketolide antibacterial,Kinase inhibitor,L-Thyroxine,L-Triiodothyronine,Lead chelator,Leukocyte growth factor,Leukotriene receptor antagonist,Lincosamide antibacterial,Lipid-based polyene antifungal,Lipopeptide antibacterial,Live attenuated Bacillus Calmette-Guerin immunotherapy,Live attenuated Bacillus Calmette-Guerin vaccine,Live attenuated mumps virus vaccine,Live human adenovirus type 4 vaccine,Live human adenovirus type 7 vaccine,Live rotavirus vaccine,Local anesthetic,Loop diuretic,Low molecular weight heparin,Lymphocyte growth factor,Macrolide,Macrolide antibacterial,Macrolide antimicrobial,Mast cell stabilizer,Megakaryocyte growth factor,Melanin synthesis inhibitor,Melatonin receptor agonist,Metal chelator,Methylated sulfonamide antibacterial,Methylating agent,Methylxanthine,Microtubule inhibitor,Monoamine oxidase inhibitor,Monoamine oxidase type B inhibitor,Monobactam antibacterial,Mood stabilizer,Mtor inhibitor immunosuppressant,Mucocutaneous epithelial cell growth factor,Mucolytic,Muscle relaxant,N-Methyl-D-aspartate receptor antagonist,N-Type calcium channel antagonist,Natriuretic peptide,Neuraminidase inhibitor,Nicotinic acid,Nitrate vasodilator,Nitrofuran antibacterial,Nitrogen binding agent,Nitroimidazole antimicrobial,Non-narcotic antitussive,Non-standardized animal dander allergenic extract,Non-standardized animal hair allergenic extract,Non-standardized animal skin allergenic extract,Non-standardized bacterial allergenic extract,Non-standardized chemical allergen,Non-standardized feather allergenic extract,Non-standardized food allergenic extract,Non-standardized fungal allergenic extract,Non-standardized house dust allergenic extract,Non-standardized insect allergenic extract,Non-standardized insect venom allergenic extract,Non-standardized plant allergenic extract,Non-standardized plant fiber allergenic extract,Non-standardized pollen allergenic extract,Noncompetitive ampa glutamate receptor antagonist,Nondepolarizing neuromuscular blocker,Nonergot dopamine agonist,Nonsteroidal anti-inflammatory drug,Norepinephrine reuptake inhibitor,"Norepinephrine, serotonin, and dopamine reuptake inhibitor anorectic",Nucleoside analog antifungal,Nucleoside analog antiviral,Nucleoside metabolic inhibitor,Omega-3 fatty acid,Opioid agonist,Opioid agonist/antagonist,Opioid antagonist,Osmotic diuretic,Osmotic laxative,Oxazolidinone antibacterial,Oxytocic,P2Y12 platelet inhibitor,Paramagnetic contrast agent,Parathyroid hormone analog,Parental iron replacement,Partial cholinergic nicotinic agonist,Partial opioid agonist,Partial opioid agonist/antagonist,Pediculicide,Penem antibacterial,Penicillin-class antibacterial,Peroxisome proliferator receptor alpha agonist,Peroxisome proliferator receptor gamma agonist,Phenothiazine,Phosphate binder,Phosphodiesterase 3 inhibitor,Phosphodiesterase 5 inhibitor,Photoactivated radical generator,Photoenhancer,Plasma volume expander,Platelet aggregation inhibitor,Platelet-reducing agent,Platinum-based drug,Pleuromutilin antibacterial,Polyene antifungal,Polyene antimicrobial,Polymyxin-class antibacterial,Porphyrin precursor,Potassium channel opener,Potassium salt,Potassium-sparing diuretic,Progesterone,Progestin,Progestin antagonist,Progestin-containing intrauterine device,Prostacycline,Prostacycline vasodilator,Prostaglandin analog,Prostaglandin E1 agonist,Prostaglandin E1 analog,Protease inhibitor,Proteasome inhibitor,Proton pump inhibitor,Provitamin D2 compound,Psoralen,Purine antimetabolite,Pyrethroid,Pyrimidine synthesis inhibitor,Pyrophosphate analog dna polymerase inhibitor,Quinolone antimicrobial,Radioactive diagnostic agent,Radioactive diagnostic agent for positron emission tomography,Radioactive therapeutic agent,Radiographic contrast agent,RANK ligand inhibitor,Recombinant antithrombin,Recombinant human deoxyribonuclease 1,Recombinant human growth hormone,Recombinant human interferon beta,Reducing and complexing thiol,Renal dehydropeptidase inhibitor,Renin inhibitor,Respiratory stimulant,Respiratory syncytial virus anti-f protein monoclonal antibody,Retinoid,Rifamycin antibacterial,Rifamycin antimycobacterial,Rna synthetase inhibitor antibacterial,Sclerosing agent,Selective T cell costimulation blocker,Selective T cell costimulation modulator,Serotonin and norepinephrine reuptake inhibitor,Serotonin reuptake inhibitor,Serotonin-1B and serotonin-1D receptor agonist,Serotonin-2C receptor agonist,Serotonin-3 receptor antagonist,Serotonin-4 receptor antagonist,Sigma-1 agonist,Skeletal muscle relaxant,Skin test antigen,Somatostatin analog,Sphingosine 1-phosphate receptor modulator,Standardized animal hair allergenic extract,Standardized animal skin allergenic extract,Standardized chemical allergen,Standardized insect allergenic extract,Standardized insect venom allergenic extract,Standardized pollen allergenic extract,Stimulant laxative,Streptogramin antibacterial,Substance P/neurokinin-1 receptor antagonist,Sucrose-specific enzyme,Sulfonamide antibacterial,Sulfonamide antimicrobial,Sulfone,Sulfonylurea,Surfactant,Sympathomimetic amine anorectic,Sympathomimetic-like agent,Tetracycline-class antibacterial,Tetracycline-class antimicrobial,Tetracycline-class drug,Thiazide diuretic,Thiazide-like diuretic,Thiazolidinedione,Thrombolytic agent,Thrombopoiesis stimulating agent,Thyroid hormone synthesis inhibitor,Thyroid stimulating hormone,Topoisomerase inhibitor,Tricyclic antidepressant,Tuberculosis skin test,Tumor necrosis factor blocker,Typical antipsychotic,Uncompetitive N-methyl-D-aspartate receptor antagonist,Unfractionated heparin,Urease inhibitor,Uric acid-specific enzyme,Vascular endothelial growth factor-directed antibody,Vasodilator,Vasopressin analog,Vasopressin antagonist,Vinca alkaloid,Vitamin A,Vitamin B complex member,Vitamin B12,Vitamin D,Vitamin D analog,Vitamin D2 analog,Vitamin D3 analog,Vitamin K,Vitamin K antagonist,Warfarin reversal agent,Xanthine oxidase inhibitor}}}
| style="width: 50%;" valign=top | {{{field|drugClass|input type=two listboxes|values=5-Alpha reductase inhibitor,5-Lipoxygenase inhibitor,Acetylcholine release inhibitor,Acetylcholine releasing agent,Actinomycin,Adenosine receptor agonist,Adrenal steroid synthesis inhibitor,Adrenergic receptor agonist,Adrenocorticotropic hormone,Aldehyde dehydrogenase inhibitor,Aldosterone antagonist,Alkylating drug,Allogeneic cord blood hematopoietic progenitor cell therapy,Allogeneic cultured cell scaffold,Allylamine antifungal,Alpha-adrenergic agonist,Alpha-adrenergic blocker,Alpha-glucosidase inhibitor,Aluminum complex,Amide local anesthetic,Amino acid,Amino acid hypertonic solution,Aminoglycoside antibacterial,Aminoketone,Aminosalicylate,Amphenicol-class antibacterial,Amphetamine anorectic,Amylin analog,Androgen,Androgen receptor inhibitor,Angiontensin converting enzyme inhibitor,Angiotensin 2 receptor blocker,Angiotensin converting enzyme inhibitor,Anthracycline topoisomerase inhibitor,Anti-anginal,Anti-coagulant,Anti-epileptic agent,Anti-IgE,Anti-inhibitor coagulant complex,Antiarrhythmic,Anticholinergic,Antidiarrheal,Antidote,Antidote for acetaminophen overdose,Antiemetic,Antifibrinolytic agent,Antihelminthic,Antihistamine,Antimalarial,Antimetabolite,Antimetabolite immunosuppressant,Antimycobacterial,Antiparasitic,Antiprotozoal,Antirheumatic agent,Antiseptic,Antivenin,Aromatase inhibitor,Aromatic amino acid decarboxylation inhibitor,Arteriolar vasodilator,Asparagine-specific enzyme,Atypical antipsychotic,Autologous cellular immunotherapy,Autologous cultured cell,Autonomic ganglionic blocker,Azole antifungal,B lymphocyte stimulator-specific inhibitor,Barbiturate,Benzodiazepine,Benzodiazepine antagonist,Benzothiazole,Benzylamine antifungal,Beta lactamase inhibitor,Beta-adrenergic agonist,Beta-adrenergic blocker,Beta2-adrenergic agonist,Beta3-adrenergic agonist,Biguanide,Bile acid,Bile acid sequestrant,Bismuth,Bisphosphonate,Blood coagulation factor,Blood viscosity reducer,Bovine intestinal adenosine deaminase,Bradykinin B2 receptor antagonist,Calcineurin inhibitor immunosuppressant,Calcitonin,Calcium,Calcium channel blocker,Calcium-sensing receptor agonist,Calculi dissolution agent,Cannabinoid,Carbamoyl phosphate synthetase 1 activator,Carbonic anhydrase inhibitor,Cardiac glycoside,Carnitine analog,Catechol-O-methyltransferase inhibitor,Catecholamine,Catecholamine synthesis inhibitor,Catecholamine-depleting sympatholytic,CCR5 co-receptor antagonist,CD20-directed cytolytic antibody,CD20-directed radiotherapeutic antibody,CD25-directed cytotoxin,CD3 blocker immunosuppressant,CD30-directed immunoconjugate,CD52-directed cytolytic antibody,Cell death inducer,Central alpha-2 adrenergic agonist,Central nervous system depressant,Central nervous system stimulant,Cephalosporin antibacterial,Chloride channel activator,Cholecystokinin analog,Cholinergic muscarinic agonist,Cholinergic muscarinic antagonist,Cholinergic nicotinic agonist,Cholinergic receptor agonist,Cholinesterase inhibitor,Cholinesterase reactivator,Collagen-specific enzyme,Complement inhibitor,Contrast agent for ultrasound imaging,Copper absorption inhibitor,Copper-containing intrauterine device,Corticosteroid,Cysteine depleting agent,Cystic fibrosis transmembrane conductance regulator potentiator,Cytochrome p450 2D6 inhibitor,Cytomegalovirus nucleoside analog DNA polymerase inhibitor,Cytoprotective agent,Decarboxylase inhibitor,Demulcent,Depigmenting agent,Depolarizing neuromuscular blocker,Diagnostic dye,Dietary cholesterol absorption inhibitor,Dihydrofolate reductase inhibitor antibacterial,Dihydrofolate reductase inhibitor antimalarial,Dihydropyridine calcium channel blocker,Dipeptidyl peptidase 4 inhibitor,Direct thrombin inhibitor,Dopamine-2 receptor antagonist,Dopaminergic agonist,Echinocandin antifungal,Endoglycosidase,Endothelin receptor antagonist,Epidermal growth factor receptor antagonist,Ergot derivative,Ergot-derived dopamine receptor agonist,Ergotamine derivative,Erythropoiesis-stimulating agent,Ester local anesthetic,Estrogen,Estrogen agonist/antagonist,Estrogen receptor antagonist,Factor VIII activator,Factor Xa inhibitor,Folate analog,Folate analog metabolic inhibitor,Gadolinium-based contrast agent,Gamma-aminobutyric acid a receptor agonist,Gamma-aminobutyric acid-ergic agonist,General anesthetic,Glinide,GLP-1 receptor agonist,Glucosylceramide synthase inhibitor,Glycopeptide antibacterial,Glycosaminoglycan,Gonadotropin,Gonadotropin releasing hormone antagonist,Gonadotropin releasing hormone receptor agonist,Growth hormone releasing factor analog,Guanylate cyclase-C agonist,Hedgehog pathway inhibitor,Helicobacter pylori diagnostic,Hematopoietic stem cell mobilizer,Heparin reversal agent,Hepatitis B virus nucleoside analog reverse transcriptase inhibitor,Hepatitis C virus NS3/4a protease inhibitor,Her2 receptor antagonist,Herpes simplex virus nucleoside analog dna polymerase inhibitor,Herpes zoster virus nucleoside analog dna polymerase inhibitor,Herpesvirus nucleoside analog dna polymerase inhibitor,Histamine-1 receptor antagonist,Histamine-1 receptor inhibitor,Histamine-2 receptor antagonist,Histone deacetylase inhibitor,HMG-CoA reductase inhibitor,Human alpha-1 proteinase inhibitor,Human antihemophilic factor,Human blood coagulation factor,Human C1 esterase inhibitor,Human immunodeficiency virus 1 fusion inhibitor,Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor,Human immunodeficiency virus integrase strand transfer inhibitor,Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor,Human immunoglobulin,Human immunoglobulin G,Human platelet-derived growth factor,Human serum albumin,Hydrolytic lysosomal glucocerebroside-specific enzyme,Hydrolytic lysosomal glycogen-specific enzyme,Hydrolytic lysosomal glycosaminoglycan-specific enzyme,Hydrolytic lysosomal neutral glycosphingolipid-specific enzyme,Hydroxyphenyl-pyruvate dioxygenase inhibitor,Immunoglobulin G,Inactivated Salmonella typhi vaccine,Influenza A M2 protein inhibitor,Inhalation diagnostic agent,Insulin,Insulin analog,Integrin receptor antagonist,Interferon alpha,Interferon gamma,Interleukin-1 receptor antagonist,Interleukin-2 receptor blocking antibody,Intestinal lipase inhibitor,Iron chelator,Ketolide antibacterial,Kinase inhibitor,L-Thyroxine,L-Triiodothyronine,Lead chelator,Leukocyte growth factor,Leukotriene receptor antagonist,Lincosamide antibacterial,Lipid-based polyene antifungal,Lipopeptide antibacterial,Live attenuated Bacillus Calmette-Guerin immunotherapy,Live attenuated Bacillus Calmette-Guerin vaccine,Live attenuated mumps virus vaccine,Live human adenovirus type 4 vaccine,Live human adenovirus type 7 vaccine,Live rotavirus vaccine,Local anesthetic,Loop diuretic,Low molecular weight heparin,Lymphocyte growth factor,Macrolide,Macrolide antibacterial,Macrolide antimicrobial,Mast cell stabilizer,Megakaryocyte growth factor,Melanin synthesis inhibitor,Melatonin receptor agonist,Metal chelator,Methylated sulfonamide antibacterial,Methylating agent,Methylxanthine,Microtubule inhibitor,Monoamine oxidase inhibitor,Monoamine oxidase type B inhibitor,Monobactam antibacterial,Mood stabilizer,Mtor inhibitor immunosuppressant,Mucocutaneous epithelial cell growth factor,Mucolytic,Muscle relaxant,N-Methyl-D-aspartate receptor antagonist,N-Type calcium channel antagonist,Natriuretic peptide,Neuraminidase inhibitor,Nicotinic acid,Nitrate vasodilator,Nitrofuran antibacterial,Nitrogen binding agent,Nitroimidazole antimicrobial,Non-narcotic antitussive,Non-standardized animal dander allergenic extract,Non-standardized animal hair allergenic extract,Non-standardized animal skin allergenic extract,Non-standardized bacterial allergenic extract,Non-standardized chemical allergen,Non-standardized feather allergenic extract,Non-standardized food allergenic extract,Non-standardized fungal allergenic extract,Non-standardized house dust allergenic extract,Non-standardized insect allergenic extract,Non-standardized insect venom allergenic extract,Non-standardized plant allergenic extract,Non-standardized plant fiber allergenic extract,Non-standardized pollen allergenic extract,Noncompetitive ampa glutamate receptor antagonist,Nondepolarizing neuromuscular blocker,Nonergot dopamine agonist,Nonsteroidal anti-inflammatory drug,Norepinephrine reuptake inhibitor,"Norepinephrine, serotonin, and dopamine reuptake inhibitor anorectic",Nucleoside analog antifungal,Nucleoside analog antiviral,Nucleoside metabolic inhibitor,Omega-3 fatty acid,Opioid agonist,Opioid agonist/antagonist,Opioid antagonist,Osmotic diuretic,Osmotic laxative,Oxazolidinone antibacterial,Oxytocic,P2Y12 platelet inhibitor,Paramagnetic contrast agent,Parathyroid hormone analog,Parental iron replacement,Partial cholinergic nicotinic agonist,Partial opioid agonist,Partial opioid agonist/antagonist,Pediculicide,Penem antibacterial,Penicillin-class antibacterial,Peroxisome proliferator receptor alpha agonist,Peroxisome proliferator receptor gamma agonist,Phenothiazine,Phosphate binder,Phosphodiesterase 3 inhibitor,Phosphodiesterase 5 inhibitor,Photoactivated radical generator,Photoenhancer,Plasma volume expander,Platelet aggregation inhibitor,Platelet-reducing agent,Platinum-based drug,Pleuromutilin antibacterial,Polyene antifungal,Polyene antimicrobial,Polymyxin-class antibacterial,Porphyrin precursor,Potassium channel opener,Potassium salt,Potassium-sparing diuretic,Progesterone,Progestin,Progestin antagonist,Progestin-containing intrauterine device,Prostacycline,Prostacycline vasodilator,Prostaglandin analog,Prostaglandin E1 agonist,Prostaglandin E1 analog,Protease inhibitor,Proteasome inhibitor,Proton pump inhibitor,Provitamin D2 compound,Psoralen,Purine antimetabolite,Pyrethroid,Pyrimidine synthesis inhibitor,Pyrophosphate analog dna polymerase inhibitor,Quinolone antimicrobial,Radioactive diagnostic agent,Radioactive diagnostic agent for positron emission tomography,Radioactive therapeutic agent,Radiographic contrast agent,RANK ligand inhibitor,Recombinant antithrombin,Recombinant human deoxyribonuclease 1,Recombinant human growth hormone,Recombinant human interferon beta,Reducing and complexing thiol,Renal dehydropeptidase inhibitor,Renin inhibitor,Respiratory stimulant,Respiratory syncytial virus anti-f protein monoclonal antibody,Retinoid,Rifamycin antibacterial,Rifamycin antimycobacterial,Rna synthetase inhibitor antibacterial,Sclerosing agent,Selective T cell costimulation blocker,Selective T cell costimulation modulator,Serotonin and norepinephrine reuptake inhibitor,Serotonin reuptake inhibitor,Serotonin-1B and serotonin-1D receptor agonist,Serotonin-2C receptor agonist,Serotonin-3 receptor antagonist,Serotonin-4 receptor antagonist,Sigma-1 agonist,Skeletal muscle relaxant,Skin test antigen,Somatostatin analog,Sphingosine 1-phosphate receptor modulator,Standardized animal hair allergenic extract,Standardized animal skin allergenic extract,Standardized chemical allergen,Standardized insect allergenic extract,Standardized insect venom allergenic extract,Standardized pollen allergenic extract,Stimulant laxative,Streptogramin antibacterial,Substance P/neurokinin-1 receptor antagonist,Sucrose-specific enzyme,Sulfonamide antibacterial,Sulfonamide antimicrobial,Sulfone,Sulfonylurea,Surfactant,Sympathomimetic amine anorectic,Sympathomimetic-like agent,Tetracycline-class antibacterial,Tetracycline-class antimicrobial,Tetracycline-class drug,Thiazide diuretic,Thiazide-like diuretic,Thiazolidinedione,Thrombolytic agent,Thrombopoiesis stimulating agent,Thyroid hormone synthesis inhibitor,Thyroid stimulating hormone,Topoisomerase inhibitor,Tricyclic antidepressant,Tuberculosis skin test,Tumor necrosis factor blocker,Typical antipsychotic,Uncompetitive N-methyl-D-aspartate receptor antagonist,Unfractionated heparin,Urease inhibitor,Uric acid-specific enzyme,Vascular endothelial growth factor-directed antibody,Vasodilator,Vasopressin analog,Vasopressin antagonist,Vinca alkaloid,Vitamin A,Vitamin B complex member,Vitamin B12,Vitamin D,Vitamin D analog,Vitamin D2 analog,Vitamin D3 analog,Vitamin K,Vitamin K antagonist,Warfarin reversal agent,Xanthine oxidase inhibitor}}}
|-
|-
| valign=top | Please describe which indications the FDA has approved the use of the drug:<BR><SMALL>
| style="width: 50%;" valign=top | Please describe which '''indications''' the FDA has approved the use of the drug:<BR><SMALL>
* '''Step 1: Check the "Indications and Usage" section from the FDA label'''<BR>
* '''Step 1: Check the "Indications and Usage" section from the FDA label'''<BR>
* '''Step 2: Enter the FDA approved indications'''<BR>
* '''Step 2: Enter the FDA approved indications'''<BR>
* '''Step 3: Fit the context: ''(Drug name)'' is ''(a/an)'' ''(category a, category b, and category c)'' drug that is FDA approved for the treatment of ''(indication a, indication b, and indication c)''.'''<BR>
* '''Step 3: Fit the context: ''(Drug name)'' is ''(a/an)'' ''(category a, category b, and category c)'' drug that is FDA approved for the treatment of ''(indication a, indication b, and indication c)''.'''<BR>
* '''Step 4: Create hyperlinks for indications'''</SMALL>
* '''Step 4: Create hyperlinks for indications'''</SMALL>
| valign=top | {{{field|indication|input type=textarea|size=35|editor|editor}}}
| style="width: 50%;" valign=top | {{{field|indication|input type=textarea|size=35|editor|editor}}}
|-
|-
| valign=top | Is there a Black Box warning associated with the drug?:<BR><SMALL>
| style="width: 50%;" valign=top | Is there a '''Black Box warning''' associated with the drug?:<BR><SMALL>
* '''Step 1: Check the "Warnings" section from the FDA label'''<BR>
* '''Step 1: Check the "Warnings" section from the FDA label'''<BR>
* '''Step 2: Select "Yes" from the drop-down menu if there is a Black Box Warning'''</SMALL>
* '''Step 2: Select "Yes" from the drop-down menu if there is a Black Box Warning'''</SMALL>
| valign=top | {{{field|hasBlackBoxWarning|input type=dropdown|values=,Yes}}}
| style="width: 50%;" valign=top | {{{field|hasBlackBoxWarning|input type=dropdown|values=,Yes}}}
|-
|-
| valign=top | Please list the most common adverse reactions associated with the drug:<BR><SMALL>
| style="width: 50%;" valign=top | Please list the '''common adverse reactions''' associated with the drug:<BR><SMALL>
* '''Step 1: Collect adverse reactions from the "Highlights of Prescribing Information" section'''<BR>
* '''Step 1: Collect adverse reactions from the "Highlights of Prescribing Information" section'''<BR>
* '''Step 2: Fit the context: Common adverse reactions include ''(reaction a, reaction b, and reaction c)''.'''
* '''Step 2: Fit the context: Common adverse reactions include ''(reaction a, reaction b, and reaction c)''.'''
* '''Step 3: Create hyperlinks for adverse reactions'''</SMALL>
* '''Step 3: Create hyperlinks for adverse reactions'''</SMALL>
| valign=top | {{{field|adverseReactions|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|adverseReactions|input type=textarea|size=35|editor}}}
|}
|}


Line 201: Line 207:
{|
{|
| style="width: 50%;" valign=top | Please enter the '''title''' of the Black Box Warning
| style="width: 50%;" valign=top | Please enter the '''title''' of the Black Box Warning
| valign=top | {{{field|blackBoxWarningTitle|input type=textarea|editor|size=40|default='''{{fontcolor|#FF0000|TITLE}}'''}}}
| style="width: 50%;" valign=top | {{{field|blackBoxWarningTitle|input type=textarea|editor|size=40|default='''{{fontcolor|#FF0000|TITLE}}'''}}}
|-
|-
| valign=top | Please enter the '''body''' of the Black Box Warning
| style="width: 50%;" valign=top | Please enter the '''body''' of the Black Box Warning
| valign=top | {{{field|blackBoxWarningBody|input type=textarea|editor|size=35|default=''{{fontcolor|#FF0000|Condition Name:}}'' (Content)}}}
| style="width: 50%;" valign=top | {{{field|blackBoxWarningBody|input type=textarea|editor|size=35|default=''{{fontcolor|#FF0000|Condition Name:}}'' (Content)}}}
|}
|}


Line 212: Line 218:


{|
{|
| style="width: 50%;" valign=top | Please enter the FDA-Labeled Indications and Dosing Information for '''Adults'''<BR><SMALL>
| style="width: 50%;" valign=top | Please enter '''FDA-labeled indications and dosing information''' for '''adults'''<BR><SMALL>
* '''Step 1: Check the "Dosage And Administration" section from the FDA label'''<BR>
* '''Step 1: Check the "Dosage And Administration" section from the FDA label'''<BR>
* '''Step 2: Insert the dosing information for each indication'''</SMALL>
* '''Step 2: Insert the dosing information for each indication'''</SMALL>
| valign=top | {{{field|fdaLIADAdult|input type=textarea|editor|size=35|default=
| style="width: 50%;" valign=top | {{{field|fdaLIADAdult|input type=textarea|editor|size=35|default=
'''Condition 1'''
'''Condition 1'''


Line 222: Line 228:
:: (Dosage)}}}
:: (Dosage)}}}
|-
|-
| valign=top | Please enter any established Off-Label Use and Dosage for '''Adults'''
| style="width: 50%;" valign=top | Please enter established '''off-label use and dosage''' for '''adults'''
|-
|-
| valign=top | Guideline-Supported Off-Label Use
| style="width: 50%;" valign=top | Enter '''guideline-supported off-label use''' in this field
| valign=top | {{{field|offLabelAdultGuideSupport|input type=textarea|size=35|editor|default=
| style="width: 50%;" valign=top | {{{field|offLabelAdultGuideSupport|input type=textarea|size=35|editor|default=
'''Condition 1'''
'''Condition 1'''


Line 238: Line 244:
:* (Dosage)}}}
:* (Dosage)}}}
|-
|-
| valign=top | Non–Guideline-Supported Off-Label Use
| style="width: 50%;" valign=top | Enter '''non–guideline-supported off-label use''' in this field
| valign=top | {{{field|offLabelAdultNoGuideSupport|input type=textarea|size=35|editor|default=
| style="width: 50%;" valign=top | {{{field|offLabelAdultNoGuideSupport|input type=textarea|size=35|editor|default=
'''Condition 1'''
'''Condition 1'''


Line 252: Line 258:


{|
{|
| style="width: 50%;" valign=top | Please enter the FDA-Labeled Indications and Dosage Information for '''Children'''<BR><SMALL>
| style="width: 50%;" valign=top | Please enter '''FDA-Labeled Indications and Dosage Information''' for '''Children'''<BR><SMALL>
* '''Step 1: Check the "Dosage And Administration" section from the FDA label'''<BR>
* '''Step 1: Check the "Dosage And Administration" section from the FDA label'''<BR>
* '''Step 2: Insert the dosing information for each indication'''</SMALL>
* '''Step 2: Insert the dosing information for each indication'''</SMALL>
| valign=top | {{{field|fdaLIADPed|input type=textarea|editor|size=35|default=
| style="width: 50%;" valign=top | {{{field|fdaLIADPed|input type=textarea|editor|size=35|default=
'''Condition 1'''
'''Condition 1'''


Line 262: Line 268:
:: (Dosage)}}}
:: (Dosage)}}}
|-
|-
| valign=top | Please enter any established Off-Label Use and Dosage for '''Children'''
| style="width: 50%;" valign=top | Please enter established '''off-label use and dosage''' for '''children'''
|-
|-
| valign=top | Guideline-Supported Off-Label Use
| style="width: 50%;" valign=top | Enter '''Guideline-Supported Off-Label Use''' in this field
| valign=top | {{{field|offLabelPedGuideSupport|input type=textarea|size=35|editor|default=
| style="width: 50%;" valign=top | {{{field|offLabelPedGuideSupport|input type=textarea|size=35|editor|default=
'''Condition 1'''
'''Condition 1'''


Line 278: Line 284:
:* (Dosage)}}}
:* (Dosage)}}}
|-
|-
| valign=top | Non-Guideline-Supported Off-Label Use
| style="width: 50%;" valign=top | Enter '''non–guideline-supported off-label use''' in this field
| valign=top | {{{field|offLabelPedNoGuideSupport|input type=textarea|size=35|editor|default=
| style="width: 50%;" valign=top | {{{field|offLabelPedNoGuideSupport|input type=textarea|size=35|editor|default=
'''Condition 1'''
'''Condition 1'''


Line 290: Line 296:


=Contraindications=
=Contraindications=


{|
{|
| style="width: 50%;" valign=top | Please enter the FDA reported contraindications:<BR><SMALL>
| style="width: 50%;" valign=top | Please enter the FDA reported '''contraindications''':<BR><SMALL>
* '''Step 1: Check the "Contraindications" section from the FDA label'''<BR>
* '''Step 1: Check the "Contraindications" section from the FDA label'''<BR>
* '''Step 2: Arrange the contents into bullet points'''</SMALL>
* '''Step 2: Arrange the contents into bullet points'''</SMALL>
| valign=top | {{{field|contraindications|input type=textarea|size=35|editor|default=
| style="width: 50%;" valign=top | {{{field|contraindications|input type=textarea|size=35|editor|default=
* Condition 1
* Condition 1
* Condition 2
* Condition 2
Line 310: Line 315:


{|
{|
| style="width: 50%;" valign=top | Please enter the FDA reported warnings associated with the drug:<BR><SMALL>
| style="width: 50%;" valign=top | Please enter the FDA reported '''warnings''' associated with the drug:<BR><SMALL>
* '''Step 1: Check the "Warnings" section from the FDA label'''<BR>
* '''Step 1: Check the "Warnings" section from the FDA label'''<BR>
* '''Step 2: Arrange the contents into bullet points'''</SMALL>
* '''Step 2: Arrange the contents into bullet points'''</SMALL>
| valign=top | {{{field|warnings|input type=textarea|size=35|editor|default=
| style="width: 50%;" valign=top | {{{field|warnings|input type=textarea|size=35|editor|default=
 
'''Conidition 1'''
'''Conidition 1'''


(Description)
(Description)
}}}
}}}
|}
|}
Line 326: Line 328:


=Adverse Reactions=
=Adverse Reactions=
{|
{|
!Please enter the adverse reactions reported from Clinical Trial Experience
| style="width: 50%;" valign=top | Please enter the '''adverse reactions''' reported from '''clinical trial experience''':<BR><SMALL>
| {{{field|clinicalTrials|input type=textarea|size=35|editor}}}
* '''Step 1: Check the "Adverse Reactions" section from the FDA label'''<BR>
* '''Step 2: Arrange the contents based on organ systems'''</SMALL>
| style="width: 50%;" valign=top | {{{field|clinicalTrials|input type=textarea|size=35|editor|default=
'''Central Nervous System'''
 
: (list/description of adverse reactions)
 
'''Cardiovascular'''
 
: (list/description of adverse reactions)
 
'''Respiratory'''
 
: (list/description of adverse reactions)
 
'''Gastrointestinal'''
 
: (list/description of adverse reactions)
 
'''Hypersensitive Reactions'''
 
: (list/description of adverse reactions)
 
'''Miscellaneous'''
 
: (list/description of adverse reactions)
 
}}}
|-
|-
!Please enter the adverse reactions reported from Postmarketing Experience
| style="width: 50%;" valign=top | Please enter the '''adverse reactions''' reported from '''postmarketing experience'''<BR><SMALL>
|{{{field|postmarketing|input type=textarea|size=35|editor}}}
* '''Step 1: Check the "Adverse Reactions" section from the FDA label'''<BR>
* '''Step 2: Arrange the contents based on organ systems'''</SMALL>
| style="width: 50%;" valign=top | {{{field|postmarketing|input type=textarea|size=35|editor|default=
'''Central Nervous System'''
 
: (list/description of adverse reactions)
 
'''Cardiovascular'''
 
: (list/description of adverse reactions)
 
'''Respiratory'''
 
: (list/description of adverse reactions)
 
'''Gastrointestinal'''
 
: (list/description of adverse reactions)
 
'''Hypersensitive Reactions'''
 
: (list/description of adverse reactions)
 
'''Miscellaneous'''
 
: (list/description of adverse reactions)
 
}}}
|}
|}


=Drug Interactions=
=Drug Interactions=
{|
{|
!Please enter the known drug interactions:
| style="width: 50%;" valign=top | Please enter established drug interactions:<BR><SMALL>
| {{{field|drugInteractions|input type=textarea|size=35|editor}}}
* '''Step 1: Check the "Drug Interactions" section from the FDA label'''<BR>
* '''Step 2: Arrange the contents into bullet points'''</SMALL>
| style="width: 50%;" valign=top | {{{field|drugInteractions|input type=textarea|size=35|editor|default=
* (Drug 1)
:* (Description)
 
* (Drug 2)
:* (Description)
 
* (Drug 3)
:* (Description)
}}}
|}
|}


=Use in Specific Populations=
=Use in Specific Populations=
{|
{|
!FDA Pregnancy Category: {{{field|FDAPregCat|input type=dropdown|values=A,B,C,D,X,N}}}
| style="width: 50%;" valign=top | FDA Pregnancy Category: {{{field|FDAPregCat|input type=dropdown|values=A,B,C,D,X,N}}}
|-
|-
!Please enter any information related to the FDA reported pregnancy category
| style="width: 50%;" valign=top | Please enter information related to the FDA reported pregnancy category
| {{{field|useInPregnancyFDA|input type=textarea|size=35|editor}}}
| {{{field|useInPregnancyFDA|input type=textarea|size=35|editor}}}
|-
|-
!Australian Pregnancy Category: {{{field|AUSPregCat|input type=dropdown|values=A,B1,B2,B3,C,D,X}}}
| style="width: 50%;" valign=top | Australian Pregnancy Category: {{{field|AUSPregCat|input type=dropdown|values=A,B1,B2,B3,C,D,X}}}
|-
|-
!Please enter any information related to the Australian reported pregnancy category
| style="width: 50%;" valign=top | Please enter information related to the Australian reported pregnancy category
| {{{field|useInPregnancyAUS|input type=textarea|size=35|editor}}}
| {{{field|useInPregnancyAUS|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug during Labor and Delivery
| style="width: 50%;" valign=top | Please enter information related to the use of the drug during labor and delivery
|{{{field|useInLaborDelivery|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInLaborDelivery|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug during Nursing
| style="width: 50%;" valign=top | Please enter information related to the use of the drug during nursing
|{{{field|useInNursing|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInNursing|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Pediatrics
| style="width: 50%;" valign=top | Please enter information related to the use of the drug in pediatrics
|{{{field|useInPed|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInPed|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Geriatrics
| style="width: 50%;" valign=top | Please enter information related to the use of the drug in geriatrics
|{{{field|useInGeri|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInGeri|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug and Gender
| style="width: 50%;" valign=top | Please enter information related to the use of the drug and gender
|{{{field|useInGender|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInGender|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug and Race
| style="width: 50%;" valign=top | Please enter information related to the use of the drug and race
|{{{field|useInRace|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInRace|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in patients with Renal Impairment
| style="width: 50%;" valign=top | Please enter information related to the use of the drug in patients with renal impairment
|{{{field|useInRenalImpair|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInRenalImpair|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in patients with Hepatic Impairment
| style="width: 50%;" valign=top | Please enter information related to the use of the drug in patients with hepatic impairment
|{{{field|useInHepaticImpair|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInHepaticImpair|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Females of Reproductive Potential and Males
| style="width: 50%;" valign=top | Please enter information related to the use of the drug in females of reproductive potential and males
|{{{field|useInReproPotential|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInReproPotential|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the use of the drug in Immunocompromised Patients
| style="width: 50%;" valign=top | Please enter information related to the use of the drug in immunocompromised patients
|{{{field|useInImmunocomp|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|useInImmunocomp|input type=textarea|size=35|editor}}}
|-
|-
!Others
| style="width: 50%;" valign=top | Others
|Title of Section: {{{field|othersTitle|input type=text|size=40}}}
|Title of Section: {{{field|othersTitle|input type=text|size=40}}}
Body: {{{field|useInOthers|input type=textarea|size=35|editor}}}
Body: {{{field|useInOthers|input type=textarea|size=35|editor}}}
|}
|}


=Administration and Monitoring=
=Administration and Monitoring=
{|
{|
!Please enter information pertaining to drug administration here
| style="width: 50%;" valign=top | Please enter information pertaining to drug administration here
| {{{field|administration|input type=textarea|size=35|editor}}}
| {{{field|administration|input type=textarea|size=35|editor}}}
|-
|-
!Please enter information pertaining to the drug monitoring here
| style="width: 50%;" valign=top | Please enter information pertaining to the drug monitoring here
|{{{field|monitoring|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|monitoring|input type=textarea|size=35|editor}}}
|}
|}


=IV Compatibility=
=IV Compatibility=
{|
{|
!Please enter information pertaining to the IV Compatibility here
| style="width: 50%;" valign=top | Please enter information pertaining to the IV compatibility here
|{{{field|IVCompat|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|IVCompat|input type=textarea|size=35|editor}}}
|}
|}


=Overdose=
=Overdose=
{|
{|
!Please enter information pertaining to the drug Overdose here
| style="width: 50%;" valign=top | Please enter information pertaining to the drug overdose here
|{{{field|overdose|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|overdose|input type=textarea|size=35|editor}}}
|}
|}


=Pharmacology=
=Pharmacology=
{|
{|
!Please enter the DrugBox template in its entirety here:
| style="width: 50%;" valign=top | Please enter the <u>DrugBox2</u> template here:<BR><SMALL>
|{{{field|drugBox|input type=textarea|size=35|editor}}}
* '''Step 1: Construct the <u>Drugbox2</u> template based on the original drugbox template'''<BR>
* '''Step 2: Cultivate the structure image from [https://pubchem.ncbi.nlm.nih.gov/search/index.html#collection=compounds PubChem]'''<BR>
* '''Step 3: Rename and upload the image to accommodate the Drugbox2 template'''</SMALL>
| {{{field|drugBox|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Mechanism of Action
| style="width: 50%;" valign=top | Please enter information related to the mechanism of action
| {{{field|mechAction|input type=textarea|size=35|editor}}}
| {{{field|mechAction|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Structure
| style="width: 50%;" valign=top | Please enter information related to the structure
| {{{field|structure|input type=textarea|size=35|editor}}}
| {{{field|structure|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Pharmacodynamics
| style="width: 50%;" valign=top | Please enter information related to the pharmacodynamics
|{{{field|PD|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|PD|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Pharmacokinetics
| style="width: 50%;" valign=top | Please enter information related to the pharmacokinetics
|{{{field|PK|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|PK|input type=textarea|size=35|editor}}}
|-
|-
!Please enter any information related to the Nonclinical Toxicology
| style="width: 50%;" valign=top | Please enter information related to the nonclinical toxicology
|{{{field|nonClinToxic|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|nonClinToxic|input type=textarea|size=35|editor}}}
|}
|}


=Clinical Studies=
=Clinical Studies=
{|
{|
!Please enter information pertaining to the Clinical Studies of the drug
| style="width: 50%;" valign=top | Please enter information pertaining to the clinical studies of the drug
|{{{field|clinicalStudies|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|clinicalStudies|input type=textarea|size=35|editor}}}
|}
|}


=How Supplied=
=How Supplied=
{|
{|
!Please enter information pertaining to the How the Drug is Supplied
| style="width: 50%;" valign=top | Please enter information pertaining to how the drug is supplied
|{{{field|howSupplied|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|howSupplied|input type=textarea|size=35|editor}}}
|-
|-
!Storage:
| style="width: 50%;" valign=top | Please enter information pertaining to how the drug should be stored:
|{{{field|storage|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|storage|input type=textarea|size=35|editor}}}
|}
|}


=Free Text for Image Section=
=Free Text for Image Section=
{|
{|
!Please enter information pertaining to the Drug Images here
| style="width: 50%;" valign=top | Please enter information pertaining to the drug images here
|{{{field|drugImages|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|drugImages|input type=textarea|size=35|editor}}}
|-
|-
!Please enter information pertaining to the FDA Package Label here
| style="width: 50%;" valign=top | Please enter information pertaining to the FDA package label here
|{{{field|packLabel|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|packLabel|input type=textarea|size=35|editor}}}
|}
|}


=Patient Information=
=Patient Information=
{|
{|
!Please enter the FDA Provided Patient Information here
| style="width: 50%;" valign=top | Please enter the FDA provided patient information here
|{{{field|fdaPatientInfo|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|fdaPatientInfo|input type=textarea|size=35|editor}}}
|-
|-
!Please enter the NLM Provided Patient Information Here
| style="width: 50%;" valign=top | Please enter the NLM provided patient information Here
|{{{field|nlmPatientInfo|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|nlmPatientInfo|input type=textarea|size=35|editor}}}
|}
|}


=Precautions with Alcohol=
=Precautions with Alcohol=
Please describe any guidelines on the concurrent use of the drug with the consumption of alcohol:
 
{{{field|alcohol|input type=textarea|size=35|editor}}}
'''{|'''
| style="width: 50%;" valign=top | Please describe any guideline on the concurrent use of the drug with alcohol:
| style="width: 50%;" valign=top | {{{field|alcohol|input type=textarea|size=35|editor}}}
<font color="#777777">|}</font>


=Look-Alike Drug Names=
=Look-Alike Drug Names=
Please enter any drug names that could be confused for the drug whose page is currently being created.
Please enter drug names that could be confused for the drug whose page is currently being created.
{{{field|lookAlike|input type=textarea|size=35|editor}}}
{{{field|lookAlike|input type=textarea|size=35|editor}}}


=Price=
=Price=
{|
{|
!Please enter the drugs a patient may want to compare for Price
| style="width: 50%;" valign=top | Please enter the drugs a patient may want to compare for Price
|{{{field|price|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|price|input type=textarea|size=35|editor}}}
|}
|}


=Drug Shortages=
=Drug Shortages=
{|
{|
!Please enter information relevant to Drug Shortages
| style="width: 50%;" valign=top | Please enter information relevant to Drug Shortages
|{{{field|drugShortage|input type=textarea|size=35|editor}}}
| style="width: 50%;" valign=top | {{{field|drugShortage|input type=textarea|size=35|editor}}}
|}
|}


Line 500: Line 606:
{{{field|pillImprint|input type=text|size=40}}}
{{{field|pillImprint|input type=text|size=40}}}


Dosage: {{{field|dosageValue|input type=text|size=40}}} {{{field|dosageUnit| input type=dropdown|values=ug,mg,g,kg,,uL,mL (cc),dL,L,,gtt(s),AU,IU,umol,mmol,U}}}
Dosage:&nbsp;&nbsp;{{{field|dosageValue|input type=text|size=40}}} {{{field|dosageUnit| input type=dropdown|values=ug,mg,g,kg,,uL,mL (cc),dL,L,,gtt(s),AU,IU,umol,mmol,U}}}


If the dosage does not fit the above format, you may enter it here: {{{field|dosageFreeText|input type=text|size=40}}}
If the dosage does not fit the above format, you may enter it here: {{{field|dosageFreeText|input type=text|size=40}}}

Revision as of 23:06, 1 May 2014


Retrieved from "https://www.wikidoc.org/index.php?title=Form:DrugProjectForm&oldid=967920"